Merck 2014 Annual Report Download - page 123
Download and view the complete annual report
Please find page 123 of the 2014 Merck annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113 -
114 -
115 -
116 -
117 -
118 -
119 -
120 -
121 -
122 -
123 -
124 -
125 -
126 -
127 -
128 -
129 -
130 -
131 -
132 -
133 -
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
-
215
-
216
-
217
-
218
-
219
-
220
-
221
-
222
-
223
-
224
-
225
-
226
-
227
-
228
-
229
-
230
-
231
-
232
-
233
-
234
-
235
-
236
-
237
-
238
-
239
-
240
-
241
-
242
-
243
-
244
-
245
-
246
-
247
-
248
-
249
-
250
-
251
-
252
-
253
-
254
-
255
-
256
-
257
-
258
-
259
-
260
-
261
-
262
-
263
-
264
-
265
-
266
-
267
-
268
-
269
-
270
-
271
 |
 |
118 GROUP MANAGEMENT REPORT → REPORT ON ECONOMIC POSITION → Life Science
LIFE SCIENCE →
SALES COMPONENTS BY BUSINESS AREA – 2014
€ million / change in % Sales Organic growth
Exchange rate
effects
Acquisitions /
divestments Total change
Bioscience 402.5 – 0.5 – 0.9 – –1.4
Lab Solutions 1,092.6 1.9 – 2.4 –– 0.5
Process Solutions 1,187.4 8.9 –1.1 –1.8 6.0
The results of operations developed as follows:
LIFE SCIENCE →
RESULTS OF OPERATIONS
2014 20131 Change
€ million in % € million in % € million in %
Sales 2,682.5 100.0 2,627.5 100.0 55.0 2.1
Royalty, license and commission income 14.0 0.5 17.8 0.7 – 3.8 – 21.4
Total revenues 2,696.5 100.5 2,645.3 100.7 51.2 1.9
Cost of sales1–1,168.7 – 43.6 –1,152.3 – 43.9 –16.4 1.4
(of which: amortization of intangible assets) 1 (– 47.6) (– 48.0) (0.4) (– 0.8)
Gross profit11,527.8 57.0 1,493.0 56.8 34.8 2.3
Marketing and selling expenses1– 844.1 – 31.5 – 835.2 – 31.8 – 8.9 1.1
(of which: amortization of intangible assets) 1 (– 151.8) (– 151.9) (0.1) (– 0.1)
Royalty, license and commission expenses –15.6 – 0.6 –16.1 – 0.6 0.5 – 3.1
Administration expenses –110.4 – 4.1 – 99.2 – 3.8 –11.2 11.3
Research and development costs1–162.6 – 6.1 –159.8 – 6.1 – 2.8 1.8
(of which: amortization of intangible assets) 1 (–) (–) (–) (–)
Other operating expenses and income –105.9 – 3.9 –120.7 – 4.6 14.8 –12.3
Operating result (EBIT) 289.2 10.8 262.0 10.0 27.2 10.4
Depreciation / Amortization / Reversals of impairments 309.7 11.5 327.8 12.5 –18.1 – 5.6
(of which: one-time items) (–) (17.3) (– 17.3) (–)
EBITDA 598.9 22.3 589.8 22.4 9.1 1.5
Restructuring costs 11.9 25.4 –13.5 – 53.2
Integration costs / IT costs 31.6 23.9 7.7 32.5
Gains / losses on the divestment of businesses – 0.4 0.5 – 0.9 –
Acquisition-related one-time items 16.6 – 16.6 –
Other one-time items – 3.2 – 3.2 –
EBITDA pre one-time items 658.6 24.6 642.8 24.5 15.8 2.5
1 The disclosure of amortization of intangible assets (excluding software) has been changed. See “Accounting and measurement principles“ in the Notes to the Group accounts.